Latest news with #Ghanghoria
Time of India
01-06-2025
- Health
- Time of India
MGM successfully treats blood cancer patient with CAR T-Cell therapy
Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy, making it the first govt medical institution in the state to do so. Tired of too many ads? go ad free now "The groundbreaking treatment was carried out under the supervision of department of clinical haematology, transfusion medicine, and bone marrow transplant," MGMMC dean Dr Arvind Ghanghoria said. He added that the patient, whose treatment began on Jan 26 this year at the Super Speciality Hospital, was successfully discharged on Saturday, four months after the therapy. Explained the CAR T-cell therapy process, Dr Ghanghoria said, "The patient undergoes an apheresis procedure to remove white blood cells. A normal patient's blood contains two types of white blood cells, B and T cells. T cells are separated from the white blood cells and then genetically modified using viral vectors. These genetically modified CAR T-cells are then re-infused into the patient. The Chimeric Antigen Receptor identifies specific proteins on the surface of cancer cells and destroys them. In this way, CAR T-cells eliminate cancer from the patient's body, leading to a cancer-free life," he said. Head of clinical haematology department Dr Akshay Lahoti highlighted that similar CAR T-cell therapy treatments abroad can cost up to Rs 4 crore. He extended gratitude for the extensive support received from various individuals and organisations, including Dr Rahul Bhargava (head haematologist, Fortis Hospital), Dr Sudhir Kataria, Dr Preeti Malpani, Dr Prachi Chaudhary, Dr Ashok Yadav, Dr Sumit Shukla, and others. Tired of too many ads? go ad free now Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy, making it the first govt medical institution in the state to do so. "The groundbreaking treatment was carried out under the supervision of department of clinical haematology, transfusion medicine, and bone marrow transplant," MGMMC dean Dr Arvind Ghanghoria said. He added that the patient, whose treatment began on Jan 26 this year at the Super Speciality Hospital, was successfully discharged on Saturday, four months after the therapy. Explained the CAR T-cell therapy process, Dr Ghanghoria said, "The patient undergoes an apheresis procedure to remove white blood cells. A normal patient's blood contains two types of white blood cells, B and T cells. T cells are separated from the white blood cells and then genetically modified using viral vectors. These genetically modified CAR T-cells are then re-infused into the patient. The Chimeric Antigen Receptor identifies specific proteins on the surface of cancer cells and destroys them. In this way, CAR T-cells eliminate cancer from the patient's body, leading to a cancer-free life," he said. Head of clinical haematology department Dr Akshay Lahoti highlighted that similar CAR T-cell therapy treatments abroad can cost up to Rs 4 crore. He extended gratitude for the extensive support received from various individuals and organisations, including Dr Rahul Bhargava (head haematologist, Fortis Hospital), Dr Sudhir Kataria, Dr Preeti Malpani, Dr Prachi Chaudhary, Dr Ashok Yadav, Dr Sumit Shukla, and others.
Time of India
16-05-2025
- Politics
- Time of India
HC issues notices in plea for flyover construction in Jabalpur constituency
Bhopal/Jabalpur: A division bench of the MP high court has issued notices to respondents in a petition filed by the Congress MLA from Jabalpur (East), Lakhan Ghanghoria. The petition seeks court intervention for the construction of a flyover in his constituency, which was sanctioned seven years ago, but the construction never commenced. He said excessive traffic pressure due to the absence of a flyover in the area is a major problem for commuters. Ghanghoria, in his petition, mentioned that in his constituency, the construction of a flyover is proposed from Ambedkar Chowk to Abdul Hamid Chowk. In 2019, the length of the flyover was 3.2 km, and the estimated cost was Rs 186 crore. By 2024, the length of the flyover increased to 5.1 km, and its cost tripled. He noted that the work on the construction of the flyover has not yet begun, while traffic in the area has increased significantly, leading to frequent jams on the roads. However, during the initial arguments over the petition, the state govt described the petition as politically motivated. Following these initial arguments, the court issued notices to respondents, including principal secretaries of PWD and urban administration department, the district collector of Jabalpur, seeking their response.
